|
Where does
it come from?
Endotoxin in
the bloodstream, termed endotoxemia, comes from two sources:
Gut-derived
endotoxin
is a major route of exposure for patients who have undergone
surgery, burns, trauma, liver failure or the critically ill.
The effects
of LPS
Eukaryotic
organisms and bacteria have co-existed since the origin of
eukaryotic cells. Because of this co-evolutionary exposure,
humans have developed a system for recognition and removal
of endotoxin. The large amount of endotoxin in the gut makes it
inevitable that the bloodstream and other tissues will be
exposed to low-dose amounts of endotoxin on a regular basis.
Endotoxin is an
incredibly potent initiator of immune cascades. Quantities
as small as pg/mL injected intravenously can rapidly lead to
vascular collapse, inflammation, coagulation and multiple
organ failure, characteristic of severe sepsis.
Detection
of Endotoxin
Endotoxin is the most
important microbial mediator yet, until the EAA™, there has
been no reliable method to measure it accurately in the
blood stream.
The EAA™
Endotoxin Activity Assay is a rapid whole blood test.
The test relies on the reaction of Lipid A with a highly
specific antibody in the milieu of the patients own
neutrophils. Based on the biologic principles of innate
immunity, the antigen-antibody complex is phagocytized by
the neutrophil, which has been primed with zymosan. The
neutrophil undergoes a series of intracellular reactions
resulting in the release of oxyradicals, which are captured
by a reagent lumiphor. The light units produced are counted
in a chemiluminometer. The magnitude of the priming
influence amount of light over time is proportional to the
concentration of antigen-antibody complexes in the patient’s
blood sample. |